Sanofi For Flu and More The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza. New mRNA Vaccine Interest Sanofi plans to invest more than $400 million a year in mRNA vaccine research, the Wall Street Journal reports. Sanofi, GSK Report Promising Results The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results. Sanofi to Test Vaccine Candidate The Financial Times reports that Sanofi and Translate Bio hope to enroll 415 participants into a Phase 1/2 trial of a candidate mRNA-based vaccine for SARS-CoV-2. Pasteur Ends Vaccine Push The Guardian reports that Pasteur Institute researchers are halting their development of a SARS-CoV-2 vaccine following disappointing initial results. May 29, 2018 Sanofi Partners with Adaptive Biotechnologies for Multiple Myeloma Trials Jan 30, 2018 NIH Launches Parkinson's Disease Research Partnership Oct 30, 2017 Berg Partners With Sanofi on Flu Biomarker Research Oct 25, 2016 Myriad RBM, Sanofi Partner to Identify CV Biomarkers in Diabetes Patients Jan 5, 2016 Sanofi Partners With Global Genomics Group on Cardiovascular Diseases Nov 18, 2015 Researchers Identify Cardiovascular Protein Markers Using Samples From Sanofi’s ORIGIN Study Premium Apr 21, 2015 Sanofi Joins Canadian Cancer Testing Consortium Dec 15, 2014 Study Shows Promise of NGS, qPCR to Detect Vaccine Contaminants Premium Nov 24, 2014 Data Point to Regulus Alport Drug Use in Late-stage Disease, Other Kidney Diseases Premium Sep 25, 2014 IP Update: Recent Patents Awarded to Alnylam, GE Healthcare, Sanofi, and More Premium Aug 27, 2014 Illumina CDx Development Deal Shows Pharma Ready to Embrace New NGS Panel Testing Paradigm Premium Aug 21, 2014 Illumina to Develop NGS-based Oncology Companion Dx with AstraZeneca, Janssen Biotech, Sanofi Apr 16, 2014 Lawsuit in Hawaii against Plavix Sponsors Alleges Burden is on Pharma to Market PGx Information Premium Apr 9, 2014 At AACR, Researchers Highlight Multiple Roles of microRNAs in Cancer Feb 6, 2014 Regulus, Sanofi Renew microRNA Drug Alliance under New Terms Premium Nov 14, 2013 Regulus Considers miR-21 Drug as Next Clinical Candidate amid Positive Alport Data Premium Oct 1, 2013 Sanofi to Evaluate Hurel's Cell-based Technology for Drug Development Aug 15, 2013 Regulus On Track for HCV Phase I in ’14, Renegotiating Sanofi Partnership Premium Jun 19, 2013 Sanofi, Curie Institute Using Sequencing Technologies on Ovarian Cancer Collaboration Apr 30, 2013 NextBio, Sanofi Collaborate on Translating Molecular Data Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.